Revisiting patient-related barriers to cancer pain management in the context of the US opioid crisis.
Revisiting patient-related barriers to cancer pain management in the context of the US opioid crisis.
复制标题
在美国阿片类药物危机的背景下，重新审视癌症疼痛管理的患者相关障碍。
DOI：
10.1097/j.pain.0000000000002173
复制
发表时间：
2021-06-01
期刊：
影响因子：
7.4
通讯作者：
Cleary J
中科院分区：
文献类型：
--
作者：
Kwekkeboom K;Serlin RC;Ward SE;LeBlanc TW;Ogunseitan A;Cleary J
Patient fear of addiction is a well-documented barrier to the use of analgesic medications for cancer pain control. Over the past 2 decades in the US, an “opioid crisis” has arisen, accompanied by risk messages delivered through news outlets, public health education, and patient-provider communication. The purpose of this study was to determine if patient-related barriers to cancer pain management – specifically, fears of addiction –and related pain outcomes (pain severity, pain interference with daily life, and adequacy of pain management) have worsened over the last 20 years. A sample of 157 outpatients with active recurrent or active metastatic cancer completed the Barriers Questionnaire-II (BQ-II) and measures of pain and analgesic use. We identified 7 comparison studies published between 2002 and 2020 that reported patient-related barriers using the BQ-II. Significant linear relationships were found between later year of publication and greater fear of addiction (Harmful Effect subscale score, B=.0350, R2=.0347, F1,637=23.19, p<.0001) and between year of publication and more pain management barriers overall (total BQ-II score, B=.039, R2=.065, F1,923=73.79, p<.0001). Relationships between BQ-II scores (harmful effect and total) and pain outcomes did not change over time. Despite worsening in patient-related barriers, the proportion of patients with adequate versus inadequate analgesic use did not differ over time. Notably, 40% of participants reported inadequate analgesic use, a statistic that has not improved in 20 years. Additional research is necessary to clarify factors contributing to changing beliefs. Findings indicate a continuing need for clinical and possibly system/policy-level interventions to support adequate cancer pain management.
登录
查看更多内容
影响因子：
--
作者：
通讯作者：
--
影响因子：
4.7
作者：
DAR, R;BEACH, CM;CLEELAND, CS
通讯作者：
CLEELAND, CS
CDC规定慢性疼痛的阿片类药物的指南 - 美国，2016年。
DOI：
10.1001/jama.2016.1464
发表时间：
2016-04-19
期刊：
JAMA
影响因子：
--
作者：
Dowell D;Haegerich TM;Chou R
通讯作者：
Chou R
影响因子：
4.7
作者：
Borneman, Tami;Koczywas, Marianna;Ferrell, Betty
通讯作者：
Ferrell, Betty
影响因子：
5.1
作者：
McGinty, Emma E.;Stone, Elizabeth M.;Barry, Colleen L.
通讯作者：
Barry, Colleen L.